Article
Genome-wide analysis links NFATC2 with asparaginase hypersensitivity.
Blood - 2 Jul 2015
Fernandez Christian A, Smith Colton, Yang Wenjian, Mullighan Charles G, Qu Chunxu, Larsen Eric, Bowman W Paul, Liu Chengcheng, Ramsey Laura B, Chang Tamara, Karol Seth E, Loh Mignon L, Raetz Elizabeth A, Winick Naomi J, Hunger Stephen P, Carroll William L, Jeha Sima, Pui Ching-Hon, Evans William E, Devidas Meenakshi, Relling Mary V
Abstract excerpt
Asparaginase is used to treat acute lymphoblastic leukemia (ALL); however, hypersensitivity reactions can lead to suboptimal asparaginase exposure. Our objective was to use a genome-wide approach to identify loci associated with asparaginase hypersensitivity in children with ALL enrolled on St. Jude Children's Research Hospital (SJCRH) protocols Total XIIIA (n = 154), Total XV (n = 498), and Total XVI (n = 271),...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
